Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells

Japanese Journal of Cancer Research

Volumn 87, Issue 5, 1996, Pages 475-479

  Kawamoto, Shogo ^a   Deguchi, Takashi ^a   Nezasa, Shinichi ^a   Yamada, Shinichiro ^a   Okano, Manabu ^a   Kawada, Yukimichi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

ACHN; Flow cytometry; P glycoprotein; Renal adenocarcinoma; Reverse transcriptase polymerase chain reaction

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; MEDROXYPROGESTERONE ACETATE; RNA; VERAPAMIL;

ADENOCARCINOMA; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY CARCINOMA; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029944133     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00248.x     Document Type: Article

References (20)

1. Paulson, D. G., Perez, C. A. and Anderson, T. Genito-urinary malignancies. In "Cancer: Principles and Practice of Oncology," ed. V. T. De Vita, S. Hellman and S. A. Rosenberg, pp. 732-741 (1982). Lippincott, Philadelphia.
2. Fojo, A. T., Shen, D. W., Mickley, L. A., Pastan, I. and Gottesman, M. M. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. J. Clin. Oncol., 5, 1922-1927 (1987).
3. Kakehi, Y., Kanamaru, H., Yoshida, O., Ohkubo, H., Nakanishi, S. and Gottesman, M. M. Measurement of multidrug-resistance messenger RNA in urogenital cancers: elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. J. Urol., 139, 862-865 (1988).
4. Borden, E. C., Hogan, T. F. and Voelkel, J. G. Comparative antiproliferative activity in vitro of natural interferons α and β for diploid and transformed human cells. Cancer Res., 42, 4948-4953 (1982).
5. 2+ concentration. Biosci. Rep., 10, 231-237 (1990).
6. Kikuchi, H., Nishiyama, K., Sumizawa, T., Furukawa, T., Yoshimura, A. and Akiyama, S. Verapamil potentiates the effect of adriamycin and vincristine on human renal adenocarcinoma cells. Med. J. Kagoshima Univ., 43, 27-38 (1991).
7. Nishiyama, K., Shirahama, T., Yoshimura, A., Sumizawa, T., Furukawa, T., Ichikawa, M., Haraguchi, M., Akiyama, S. and Ohi, Y. Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas. Cancer, 71, 3611-3619 (1993).
8. Ueda, K., Cardarelli, C., Gottesman, M. M. and Pastan, I. Expression of a full-length cDNA for the human mdr 1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA, 84, 3004-3008 (1987).
9. Nakajima-Iijima, S., Hamada, H., Reddy, P. and Kakunaga, T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA, 82, 6133-6137 (1985).
10. Ozaki, T. Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran-coated charcoal (DCC) assay and immunocytochemical assay. Jpn. J. Cancer Chemother., 19, 361-366 (1992).
11. Kwok, S. Procedures to minimize PCR-product carry-over. In "PCR Protocols: A Guide to Methods and Applications," ed. M. A. Innis, D. H. Gelfand, J. J. Sninsky and T. J. White, pp. 142-145 (1990). Academic Press, San Diego.
12. Gheuens, E. E. O., van Bockstaele, D. R., van der Keur, M., Tanke, H. J., van Oosterom, A. T. and De Bruijin, E. A. Flow cytometric double labeling technique for screening of multidrug resistance. Cytometry, 12,636-644 (1991).
13. Krishan, A., Sauerteig, A. and Stein, J. H. Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry, 12, 731-742 (1991).
14. Durand, R. E. and Olive, P. L. Flow cytometry studies of intracellular adriamycin in single cells. Cancer Res., 41, 3489-3494 (1981).
15. Chambers, S. H., Bleehen, N. M. and Watson, J. V. Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells. Br. J. Cancer, 49, 301-306 (1984).
16. Kangas, L., Gronroos, M. and Nieminen, A.-L. Bio-luminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med. Biol., 62, 338-343 (1984).
17. Garewal, H. S., Ahmann, F. R., Schifman, R. B. and Celniker, A. ATP assay: ability to distinguish cytostatic from cytocidal anticancer drug effects. J. Natl. Cancer Inst., 77, 1039-1045 (1986).
18. Mickisch, G. H., Roehrich, K., Koessig, J., Forester, S., Tschada, R. K. and Alken, P. M. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J. Urol., 144, 755-759 (1990).
19. Slater, L. M., Sweer, P., Stupecky, M. and Gupta, S. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J. Clin. Invest., 77, 1405-1408 (1986).
20. Yang, C. P. H., De Pinho, S., Greenberger, L. M., Arceci, R. J. and Horwitz, S. B. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J. Biol. Chem., 264, 782-788 (1989).